Home › Funds › Manatuck Hill Partners, LLC › TOI

Manatuck Hill Partners, LLC position in TOI

STARLING ONCOLOGY INC COM

Manatuck Hill Partners, LLC reported holding 450,000 shares of TOI (STARLING ONCOLOGY INC COM) in its Q2 2026 13F filing — a position valued at US$2.4M, representing 0.81% of its reported portfolio and ranking #41 among its reported holdings. Manatuck Hill Partners, LLC has disclosed TOI holdings in 4 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)450.00K sh
Reported value held$2.44M
Portfolio Weight0.81%
First reportedQ1 2025
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Manatuck Hill Partners, LLC's TOI position evolved

Manatuck Hill Partners, LLC first disclosed a stake in TOI in Q1 2025 at 350,000 shares (US$399K). The position peaked in Q2 2026 at 450,000 shares, worth US$2.4M. Across 4 filings, Manatuck Hill Partners, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 450,000 shares valued at US$2.4M. Notable position changes include a 29% trim in Q2 2025, a 152% increase in Q3 2025.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 350.00K $399.00K New
Q2 2025 249.80K $512.09K Reduce
Q3 2025 629.80K $2.20M Add
Q2 2026 450.00K $2.44M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TOI and 13F data

TOI (STARLING ONCOLOGY INC COM) is a company whose sector is not yet classified in our data. 64 other funds we track also report a position in TOI — the largest reported positions include JOSH ARNOLD INVESTMENT CONSULTANT, LLC (US$13.4M), WEXFORD CAPITAL LP (US$9.3M), BRC Group Holdings, Inc. (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TOI

All TOI fund holders →

FAQ

How long has Manatuck Hill Partners, LLC held TOI?

Manatuck Hill Partners, LLC has disclosed TOI holdings in 4 of the last 6 reported quarters, going back to Q1 2025.

What is Manatuck Hill Partners, LLC's current position in TOI?

As of Q2 2026, Manatuck Hill Partners, LLC holds 450.00K shares of TOI (STARLING ONCOLOGY INC COM), valued at $2.44M, representing 0.81% of its reported portfolio and ranking #41.

Has Manatuck Hill Partners, LLC been buying or selling TOI?

In the latest 13F filing (Q2 2026), Manatuck Hill Partners, LLC newly opened its position in TOI. The position peaked in Q2 2026 at 450.00K shares.

Which other funds hold TOI?

Other major institutional holders of TOI include JOSH ARNOLD INVESTMENT CONSULTANT, LLC, WEXFORD CAPITAL LP, BRC Group Holdings, Inc., among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.